On January 6, 2015, CHIL was officially registered with the Saudi Food and Drug Authority (SFDA) through its local partner in the Kingdom of Saudi Arabia.
This registration enabled the company’s diagnostic products to be formally recognized by the Saudi regulatory authority, supporting their placement within the local healthcare market in compliance with national requirements.